Sinopoulou Vasiliki, Shah Eshan, Gordon Morris, Tony-Jimmy Tonia E
Biomedical Evidence Synthesis and Translation to Practice Unit, School of Medicine, Preston PR1 7BH, United Kingdom.
School of Medicine and Dentistry, University of Central Lancashire, Preston PR1 2HE, United Kingdom.
World J Methodol. 2025 Sep 20;15(3):95559. doi: 10.5662/wjm.v15.i3.95559.
Systematic reviews (SRs) synthesize and evaluate data, mainly from randomized trials, which then guides the development of clinical recommendations in evidence-based medicine. However, the data and methodological information in the included papers can often be lacking or unclear, and reviewers usually need to contact the authors of included studies for clarifications. Contacting authors is recommended, but it is unclear how often SR teams do it, or what the level of response is.
To investigate how often reviewers undertake contact with the authors of included randomized controlled trials (RCTs) for clarification on data and risk of bias concerns, to explore the factors that influence whether SR authors contact or do not contact the authors, and the content and level of responses.
We conducted a systematic electronic database search in MEDLINE using the search string "(systematic review)" AND "(RCT OR randomized OR trial)" for articles published between 1 January 2024 and 19 February 2024, without language restrictions. Screening and data extraction was done independently by two reviewers, and conflicts resolved by a senior author. Contact authors of included SRs were contacted for clarifications.
Of the 329 included SRs, 38% ( = 125) explicitly mentioned contact with the authors of included studies. The remaining 62% ( = 204) did not. We attempted contact with all SR teams for clarifications and received 90 responses (19.4%). Of the 50 respondents who did not explicitly mention contact in their SRs, 25 (50%) replied that they did make contact. We received a total of 64 responses on the level and content of information sought. The mean ± SD contacts SR teams made were 10 (10), replies received 5 (6.7), and response waiting time 10.1 (28.3) weeks. Resources, time, poor previous experience, perceived likelihood of poor response and bias concerns were reported as barriers to attempting contact.
The majority of SRs published in 2024 did not confirm seeking clarifying or missing information from primary study authors. However, SR teams reported that 50% of contacted primary authors respond. Additional research can clarify this rate of response and establish methods to increase the integration of this core methodological element in SRs.
系统评价(SRs)综合并评估主要来自随机试验的数据,进而指导循证医学中临床推荐的制定。然而,纳入论文中的数据和方法学信息常常缺失或不明确,综述作者通常需要联系纳入研究的作者以寻求澄清。推荐与作者进行联系,但目前尚不清楚SR团队这样做的频率以及回复率如何。
调查综述作者与纳入的随机对照试验(RCTs)的作者就数据及偏倚风险问题进行澄清的频率,探究影响SR作者是否联系作者的因素以及回复的内容和水平。
我们使用检索词“(系统评价)”和“(RCT或随机或试验)”在MEDLINE中进行了系统的电子数据库检索,以查找2024年1月1日至2024年2月19日发表的文章,无语言限制。筛选和数据提取由两名综述作者独立完成,分歧由一位资深作者解决。联系纳入SRs的作者以寻求澄清。
在纳入的329篇SRs中,38%(n = 125)明确提到与纳入研究的作者进行了联系。其余62%(n = 204)未提及。我们试图联系所有SR团队以寻求澄清,共收到90份回复(19.4%)。在其SRs中未明确提及联系的50位受访者中,25位(50%)回复称他们确实进行了联系。我们共收到64份关于所寻求信息的水平和内容的回复。SR团队进行联系的平均次数±标准差为10次(10次),收到回复5次(6.7次),回复等待时间为10.1周(±28.3周)。资源、时间、以往不佳的经历、认为回复不佳的可能性以及对偏倚的担忧被报告为尝试联系的障碍。
2024年发表的大多数SRs未证实向原始研究作者寻求澄清或缺失的信息。然而,SR团队报告称,50%的被联系的原始作者会回复。进一步的研究可以明确这一回复率,并建立方法以增加这一核心方法学要素在SRs中的整合。